Cargando…
The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML
BACKGROUND: CCAAT/enhancer-binding protein-α (CEBPA) is crucial for normal granulopoiesis and is frequently disrupted in acute myeloid leukaemia (AML). Increasing evidence suggests that CEBPA exerts its effects, in parts, by regulating specific microRNAs (miRNAs), as previously shown for miR-223. Th...
Autores principales: | Eyholzer, M, Schmid, S, Wilkens, L, Mueller, B U, Pabst, T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906742/ https://www.ncbi.nlm.nih.gov/pubmed/20628397 http://dx.doi.org/10.1038/sj.bjc.6605751 |
Ejemplares similares
-
Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis
por: Pabst, T, et al.
Publicado: (2009) -
Unfolded protein response suppresses CEBPA by induction of calreticulin in acute myeloid leukaemia
por: Schardt, Julian A, et al.
Publicado: (2010) -
MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression
por: Presneau, N, et al.
Publicado: (2013) -
Reply to ‘Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis’
por: Hou, H-A, et al.
Publicado: (2009) -
Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer
por: Kojima, S, et al.
Publicado: (2012)